Agilon Health (AGL) Reports Q3 Loss, Lags Revenue Estimates
Portfolio Pulse from
Agilon Health (AGL) reported a Q3 loss of $0.29 per share, missing the Zacks Consensus Estimate of a $0.10 loss. This is a larger loss compared to $0.06 per share a year ago.
November 07, 2024 | 11:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Agilon Health reported a larger than expected Q3 loss of $0.29 per share, missing the consensus estimate of $0.10 and increasing from last year's $0.06 loss.
The reported loss of $0.29 per share is significantly worse than the expected loss of $0.10, indicating a negative surprise for investors. This larger than expected loss, along with a year-over-year increase in losses, is likely to put downward pressure on Agilon Health's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100